A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

How Power of the Cloud and HBNS Team Save the Day for Primary Care Provider During a Pandemic

February 12, 2021

Leadership from HBNS, an IT service provider, and Santa Rosa Community Health, an essential primary health care provider, announced today that they have released a case study.

The case study shows how the two organizations collaborated together to respond quickly to the technology needs of health care staff, whose jobs were already challenging enough during these especially difficult times.

The CEO was challenged with how to serve 40,000 low-income and uninsured patients when: (1) you face destructive wildfires and a global pandemic; (2) your area has infrastructure damage, outages and massive evacuations; and (3) your Pandora’s box of IT issues wreak havoc on health clinic operations.

Santa Rosa Community Health CEO Naomi Fuchs heard the call for help from her staff and with the help of HBNS, she was able to help transform a sluggish Relevant System — processing day-to-day operational reports at night at a rate of 8 to 10 hours while often crashing–into a smooth-running system that generates reports in just 18 minutes.

HBNS Vice President of Operations Marc Whinnem said, “With reprogramming, correction of bad logic, and maximizing the power of the cloud, HBNS made it possible for clinicians to expedite patient care.”

SourceHBNS
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy